Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

SHANGHAI, Dec. 31, 2025 /PRNewswire/ -- Insilico Medicine (03696.HK), a global leader in AI-driven drug discovery and a portfolio company of Qiming Venture Partners, today successfully listed on the Hong Kong Stock Exchange (HKEX). The listing marks...

Leifras Notice regarding the conclusion of a commitment line agreement totaling 2.5 billion yen to diversify fund-raising channels and strengthen the financial base

Leifras Notice regarding the conclusion of a commitment line agreement totaling 2.5 billion yen to diversify fund-raising channels and strengthen the financial base

TOKYO, Dec. 25, 2025 /PRNewswire/ -- Leifras Co., Ltd. (NASDAQ: LFS, Head Office: Shibuya-ku, Tokyo, Representative Director: Kiyotaka Ito, hereinafter referred to as "the Company"), which operates sports schools for children and supports the local...

From Discoverative AI to the Entropy of Tolerance: Tianqiao Chen's Vision of Human-AI Co-Evolution

From Discoverative AI to the Entropy of Tolerance: Tianqiao Chen's Vision of Human-AI Co-Evolution

SAN MATEO, Calif., Dec. 24, 2025 /PRNewswire/ -- Shanda Group has entered a period of renewed visibility, with a series of incubated ventures coming to light over the past several months. At the center of this momentum is its founder, Tianqiao Chen,...

From Black Friday to Christmas: HEISR Turns Everyday Oral Care into a Gift That Lasts All Year

From Black Friday to Christmas: HEISR Turns Everyday Oral Care into a Gift That Lasts All Year

Why a Three-Sided Toothbrush Is Becoming One of the Most Thoughtful Holiday Gifts for Modern Families LAS VEGAS, Dec. 24, 2025 /PRNewswire/ -- During this year's Black Friday season, HEISR re-entered the spotlight in the U.S. market with its...

Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73

Jacobio Pharma Enters Global Exclusive License Agreement with AstraZeneca for Pan-KRAS Inhibitor JAB-23E73

BEIJING, SHANGHAI and BOSTON, Dec. 21, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK,) today announced that it has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73. AstraZeneca will receive exclusive development...

RIMAN Makes Highly Anticipated Japan Debut with Bustling Launch Events

RIMAN Makes Highly Anticipated Japan Debut with Bustling Launch Events

SEOUL, South Korea, Dec. 18, 2025 /PRNewswire/ -- RIMAN, a premium Korean skincare and wellness brand, today announced it has officially entered the Japanese market with significant momentum from two successful launch events. The events took place...

Lady M Strengthens Global Strategy in Singapore, Deepening Commitment to Southeast Asia

Lady M Strengthens Global Strategy in Singapore, Deepening Commitment to Southeast Asia

NEW YORK, Dec. 17, 2025 /PRNewswire/ -- Lady M Confections Co., Ltd. ("Lady M"), the internationally renowned luxury patisserie brand, today reaffirmed the strategic importance of Singapore within its global growth plans and announced a transition...

RayNeo solidifies its global AR market leadership in Q3 with a 24% share

RayNeo solidifies its global AR market leadership in Q3 with a 24% share

LOS ANGELES, Dec. 16, 2025 /PRNewswire/ -- RayNeo has solidified its leadership in the consumer augmented reality (AR) sector, achieving top positions in both market share and seasonal sales. According to the latest Q3 2025 Global AR Smart Glasses...

AMTD Digital's Subsidiary TGE Executed SPA to Acquire Upper View Regalia Hotel in Kuala Lumpur, Malaysia

AMTD Digital's Subsidiary TGE Executed SPA to Acquire Upper View Regalia Hotel in Kuala Lumpur, Malaysia

PARIS and NEW YORK and LONDON, Dec. 15, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD Group"), AMTD IDEA Group (NYSE: AMTD; SGX: HKB), AMTD Digital Inc. (NYSE: HKD) and The Generation Essentials Group ("TGE", NYSE & LSE: TGE), a subsidiary of AMTD...

Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.

Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.

STOCKHOLM, Dec. 15, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (STO: SOBI) recently announced that it has entered into an acquisition agreement with Arthrosi Therapeutics, Inc., which was invested in and incubated by Viva Biotech Holdings....

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • menu
    menu